Developing formulations of widely-used cancer drugs for humans and dogs.
Industry: Health Care
First Day Return: -3.9%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 07/06/2015 |
Offer Price | $4.06 |
Price Range $4.70 - $6.70 | |
Offer Shares (mm) | 2.3 |
Deal Size ($mm) | $9 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/22/2015 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $9 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Uppsala, Sweden |
Founded | 1999 |
Employees at IPO | 80 |
Website www.oasmia.com |